Market Overview

Corporate Reputation of Pharma Companies, 2017-2020 - Patient Perspective of 123 Spanish Patient Groups -


The "The
Corporate Reputation of Pharma Companies, 2017 - The Patient Perspective
of 123 Spanish Patient Groups"
report has been added to's

Spanish patient groups' attitudes toward the pharmaceutical
industry improved in 2017-though they still remain cautious about
pharma, when compared with patient groups from other countries

The Spain-wide findings of the 2017 Corporate-Reputation survey showed
that pharma's corporate reputation significantly increased in that
country, 2016 to 2017. 46% of respondent Spanish patient groups stated
that the pharma industry as a whole had an Excellent or Good corporate
reputation in 2017, compared with only 28% saying the same in 2016.
However, the percentage was even higher in Spain two years before, in
2015-at 48%.

The main drivers for the increase in the industry's corporate reputation
in Spain in 2017 appear to be a more positive attitude that Spanish
patient groups are taking to pharma companies' efforts in the fields of
patient centricity, innovation, the provision of high-quality products,
corporate integrity, working partnerships with patient groups, and the
services that pharma provides beyond the pill'.

However, despite being more favourable toward the pharmaceutical
industry in 2017, Spanish patient groups are still not as positive about
most of pharma's activities as patient groups from many other individual
parts of the world

Key Topics Covered:

  1. Executive Summary
  2. Spanish Patient-Group Relationships With Pharma, 2017
  3. Industry-Wide Findings, 2017
  4. Rankings Of The 25 Pharma Companies, 2017 V. 2016 Among Spanish
    Patient Groups Familiar With The Companies
  5. Positioning Of 16 Pharma Companies, 2017 V. 2016 Among Spanish Patient
    Groups That Work/Partner With The Companies
  6. Profiles Of The 25 Companies, 2017

Companies Mentioned

  • Abbvie
  • Almirall
  • Amgen
  • Astellas Pharma
  • Astrazeneca
  • Bayer
  • Biogen
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Eli Lilly
  • Gilead Sciences
  • Grifols
  • GSK
  • Janssen
  • Leo Pharma
  • Menarini
  • Merck & Co / Msd
  • Merck Kgaa
  • Novartis
  • Novo Nordisk
  • Otsuka
  • Pfizer
  • Roche
  • Sanofi
  • Teva

For more information about this report visit

View Comments and Join the Discussion!